Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.
Journal: Lancet (London, England)
Published: February 04, 2026
Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK.
Journal: The American journal of pathology
Published: October 12, 2021
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Journal: Leukemia
Published: November 24, 2019
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Journal: Haematologica
Published: September 19, 2019
Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/BCR-FGFR1-rearranged myeloid/lymphoid neoplasm with RUNX1 mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib.
Journal: Leukemia & lymphoma
Published: September 17, 2019
Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma.
Journal: American journal of hematology
Published: July 22, 2019
Unusual case of a myelodysplastic syndrome with novel inv(5)(q15q33).
Journal: Blood
Published: June 15, 2019
Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease.
Journal: British journal of haematology
Published: February 20, 2019
Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
Journal: Diagnostic pathology
Published: September 17, 2018
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Journal: Leukemia
Published: November 23, 2016
Last Updated: 09/26/2026